Ventas (VTR) Reports Q4 Earnings: What Key Metrics Have to Say

Core Insights - Ventas reported revenue of $1.57 billion for the quarter ended December 2025, marking a 21.7% increase year-over-year and exceeding the Zacks Consensus Estimate of $1.5 billion by 4.68% [1] - The company's EPS for the quarter was $0.89, significantly higher than $0.13 in the same quarter last year, and aligned with the consensus estimate [1] Revenue Breakdown - Interest and other income was reported at $7.88 million, surpassing the average estimate of $2.25 million, but reflecting a year-over-year decline of 5.2% [4] - Rental income from the outpatient medical and research portfolio was $226.76 million, slightly below the estimated $229.22 million, but showed a year-over-year increase of 4.9% [4] - Resident fees and services generated $1.19 billion, exceeding the average estimate of $1.11 billion, with a substantial year-over-year growth of 32.3% [4] Stock Performance - Over the past month, Ventas shares have returned 2.7%, outperforming the Zacks S&P 500 composite, which saw a 0.5% change [3] - The stock currently holds a Zacks Rank 4 (Sell), indicating potential underperformance relative to the broader market in the near term [3]